National Cancer Institute
Found 1097 results for your search:
Total relevant funding to Lung for this search:
$320,564,352
Fiscal Year FY 2017
Cancer Type [Lung]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 1097 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership 2U54CA163071-06 $1,427,230 $285,446 MATTA, JAIME PONCE SCHOOL OF MEDICINE
2
(PQ1) Epigenetic effects of the premalignant field 5R01CA208620-02 $372,671 $372,671 TERADA, LANCE UT SOUTHWESTERN MEDICAL CENTER
3
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution 1R01CA219893-01 $442,614 $442,614 GHOSH, MOUMITA NATIONAL JEWISH HEALTH
4
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer 5R01CA205608-02 $346,909 $346,909 SCHEET, PAUL UNIVERSITY OF TX MD ANDERSON CAN CTR
5
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression 3R01CA194461-03S1 $57,872 $57,872 PARK, KWON-SIK UNIVERSITY OF VIRGINIA
6
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression 5R01CA194461-03 $334,552 $334,552 PARK, KWON-SIK UNIVERSITY OF VIRGINIA
7
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer 5R01CA208642-02 $352,275 $352,275 SHACKELFORD, DAVID UNIVERSITY OF CALIFORNIA LOS ANGELES
8
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae 5R01CA208634-02 $560,277 $280,139 JURECIC, ROLAND UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
9
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy 5R01CA206028-02 $342,964 $342,964 GEWIRTZ, DAVID VIRGINIA COMMONWEALTH UNIVERSITY
10
(PQ9) Prevention of Bleomycin-induced Pulmonary Toxicity by Dichloroacetate (DCA) 5R21CA208746-02 $173,586 $173,586 KIM, JUNG-WHAN UNIVERSITY OF TEXAS DALLAS
11
(PQA3) Smartphone delivered attentional bias modification training for smokers 5R01CA184781-04 $374,101 $374,101 ROBINSON, JASON UNIVERSITY OF TX MD ANDERSON CAN CTR
12
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals 5R01CA185020-04 $325,181 $325,181 JACKS, TYLER MASSACHUSETTS INSTITUTE OF TECHNOLOGY
13
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors 5R01CA194470-03 $446,627 $151,853 JANES, KEVIN UNIVERSITY OF VIRGINIA
14
(PQD6)The Role of Immune Homeostasis in Protection from Cancer Cachexia 3R01CA185349-03S2 $96,000 $96,000 DAVIES, JOANNA SAN DIEGO BIOMEDICAL RESEARCH INSTITUTE
15
0021.0001 CG 425 METAVIVOR 261200800001E $319,219,481 $176,272 UNKNOWN, UNKNOWN LEIDOS BIOMEDICAL RESEARCH, INC.
16
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities 5P20CA202923-03 $76,675 $76,675 KHAN, SOHAIL CHEROKEE NATION
17
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 5U54CA203000-03 $1,192,293 $453,071 SIMON, MELISSA NORTHWESTERN UNIVERSITY AT CHICAGO
18
2/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities 5P20CA202921-03 $289,323 $147,555 SPICER, PAUL UNIVERSITY OF OKLAHOMA NORMAN
19
2/2 NCCU-LCCC Partnership in Cancer Research 5U54CA156733-08 $919,471 $91,947 EARP, HENRY UNIV OF NORTH CAROLINA CHAPEL HILL
20
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership 2U54CA163068-06 $1,656,304 $397,513 MUNOZ-ANTONIA, TERESITA H. LEE MOFFITT CANCER CTR & RES INST
21
2/2 The TREND Partnership: Tobacco Research and Education to Eliminate Disparities 5P20CA192991-04 $205,712 $205,712 OSTROFF, JAMIE SLOAN-KETTERING INST CAN RESEARCH
22
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 5U54CA202995-03 $820,604 $295,417 CIECIERSKI, CHRISTINA NORTHEASTERN ILLINOIS UNIVERSITY
23
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 5U54CA202997-03 $1,314,319 $39,430 WINN, ROBERT UNIVERSITY OF ILLINOIS AT CHICAGO
24
A cohort mortality study with a nested case-control study of lung cancer and dies ZIA CP010120-02091 $131,221 $131,221 Silverman, Debra DCEG (NCI)
25
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $169,821 $33,964 Rothman, Nat DCEG (NCI)
26
A Collaborative Reporting Tool For Interpreting Genomic Events In Lung Cancers 1F32CA206247-01A1 $59,166 $59,166 WAGNER, ALEX WASHINGTON UNIVERSITY
27
A Follow-up Study for Causes of Cancer in Black Women 2U01CA164974-07 $2,195,369 $439,074 ROSENBERG, LYNN BOSTON UNIVERSITY MEDICAL CAMPUS
28
A Follow-up Study for Causes of Cancer in Black Women 5UM1CA164974-06 $639,740 $127,948 ROSENBERG, LYNN BOSTON UNIVERSITY MEDICAL CAMPUS
29
A high efficiency imager for real-time lung cancer monitoring during radiotherapy 3R01CA188446-04S1 $256,320 $256,320 BERBECO, ROSS DANA-FARBER CANCER INST
30
A high efficiency imager for real-time lung cancer monitoring during radiotherapy 5R01CA188446-04 $768,460 $768,460 BERBECO, ROSS DANA-FARBER CANCER INST
31
A Hospital-based Case-Control Study of Non-smoking Women in Xuan Wei and Fu Yu ZIA CP010121-10349 $79,862 $79,862 Lan, Qing DCEG (NCI)
32
A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments 5R01CA184173-03 $363,342 $363,342 REN, LEI DUKE UNIVERSITY
33
A model for predicting response to PD-1 inhibitors in NSCLC 1R01CA208403-01A1 $639,083 $639,083 GARON, EDWARD UNIVERSITY OF CALIFORNIA LOS ANGELES
34
A multi-faceted approach to identifying K-Ras synthetic lethal relationships 5U01CA199252-03 $1,041,188 $520,594 HAIGIS, KEVIN BETH ISRAEL DEACONESS MEDICAL CENTER
35
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences 1R01CA210625-01A1 $488,627 $488,627 CARPENTER, MATTHEW MEDICAL UNIVERSITY OF SOUTH CAROLINA
36
A new generation of targeted therapeutics for the treatment of cancer. 3R41CA195926-01S1 $49,844 $49,844 PAWELCZAK, KATHERINE NERX BIOSCIENCES, INC.
37
A new imaging approach to radiotherapy planning for lung cancer 5R01CA193050-03 $535,497 $535,497 RIZI, RAHIM UNIVERSITY OF PENNSYLVANIA
38
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers 5R01CA191489-03 $380,278 $380,278 NGUYEN, DON YALE UNIVERSITY
39
A novel preclinical model of spontaneous metastasis ZIA BC 011167 $524,680 $26,234 Merlino, Glenn CCR (NCI)
40
A Novel Worksite Smoking Cessation intervention for Hispanic Construction Workers 5R21CA202993-02 $166,931 $166,931 LEE, DAVID UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
41
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients 5R01CA187143-04 $456,456 $456,456 BADR, HODA BAYLOR COLLEGE OF MEDICINE
42
A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy 5R44CA213507-02 $642,098 $642,098 PHILIBERT, ROBERT BEHAVIORAL DIAGNOSTICS, INC.
43
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer 5R01CA207133-02 $554,387 $554,387 WINSLOW, MONTE STANFORD UNIVERSITY
44
A Randomized Trial of Incentives for Research Participation 5R01CA197332-03 $615,864 $615,864 HALPERN, SCOTT UNIVERSITY OF PENNSYLVANIA
45
A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases 1R21CA214299-01 $240,785 $60,196 SLATER, JOHN UNIVERSITY OF DELAWARE
46
AARP prospective study of diet and cancer ZIA CP010196-03152 $703,174 $35,159 Sinha, Rashmi DCEG (NCI)
47
Abramson Cancer Center Support Grant 3P30CA016520-41S1 $125,000 $17,500 DANG, CHI UNIVERSITY OF PENNSYLVANIA
48
Abramson Cancer Center Support Grant 3P30CA016520-41S2 $62,491 $8,749 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
49
Abramson Cancer Center Support Grant 5P30CA016520-41 $7,810,244 $1,093,434 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
50
Accountability for Cancer Care through Undoing Racism and Equity (ACCURE) 3R01CA150980-05S2 $149,065 $74,533 ENG, EUGENIA UNIV OF NORTH CAROLINA CHAPEL HILL
Total relevant funding to Lung for this search: $320,564,352
Showing 1 - 50 of 1097 results
Go to top